Axonics, Inc. (AXNX) stock declined over -1.75% intraday to trade at $56.67 a share on NASDAQ. The stock opened with a gain of 0.76% at $56.62 and touched an intraday high of $57.99, falling -1.75% against the last close of $57.68. The stock went to a low of $55.34 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue180.29 Million
5Y Sales Change-
Fiscal Year Ends2021-12-30
IndustryHealth Care Equipment
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
Axonics, Inc. (NASDAQ: AXNX) stock price is $56.67 as of the last check on Thursday, June 30. During the trading session, AXNX stock reached the peak price of $57.99 while $55.34 was the lowest point it dropped to.
The NASDAQ listed AXNX is part of Health Care Equipment industry that operates in the broader Health Care sector. Axonics, Inc. , a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems.
Mr. Raymond W. Cohen
CEO & Director
Mr. Danny L. Dearen
Pres & CFO
Mr. Rinda K. Sama
Chief Operating Officer
Dr. John Woock Ph.D.
Exec. VP, Chief Marketing & Strategy Officer
AXNX stock traded closed the last session at $56.67, which is $-1.01 or -1.75% lower than its previous close of $57.68. AXNX's current trading price is 47.54% lower than its 52-week high of $79.81 where as its distance from 52-week low of 38.41% is -28.99%.
Number of AXNX employees currently stands at -. AXNX operates from 26 Technology Drive, Irvine, CA 92618, United States.
Official Webiste of $AXNX is: https://www.axonics.com
AXNX stock volume for the day was 362,458 shares while in the previous session number of AXNX shares traded was 356,654 . The average number of AXNX shares traded daily for last 3 months was 549.11 Thousands.
The percentage change in AXNX stock occurred in the recent session was -1.75% while the dollar amount for the price change in AXNX stock was $-1.01.
In the recent session, the day high for AXNX stock was $57.99 while the low for AXNX stock touched on the day was $55.34.
The market value of AXNX currently stands at 2.58 Billion with its latest stock price at $56.67 and 45.14 Million of its shares outstanding.